Marvel Biosciences Corp (TSE:MRVL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Marvel Biosciences Corp. has granted incentive stock options for its directors and officers to purchase 1,475,000 common shares at $0.125 each, matching the closing price on the TSX Venture Exchange the day before the grant. These options are exercisable until July 2029, with a vesting schedule that allows for immediate access to a third, and the remainder over the next two years.
For further insights into TSE:MRVL stock, check out TipRanks’ Stock Analysis page.